Investigation of vaccine case

Report list

• 

  Prosecutors probe local health agency for failing to monitor vaccination

  The procuratorate of Pianguan county in North China's Shanxi Province has begun investigating the local commission of health and family planning of failing to monitor the irregular vaccination.

• 

  Major progress in vaccine scandal

  (File photo)Major progress has been made in the fraud case against Changchun Changsheng Bio-tech Co, according to investigators for the State Council on Friday.Recently, the company was found to have falsified production and inspection data on a freeze-dried rabies vaccine for human use, triggering wide criticism among the public.According to a journalist who witnessed the investigators in action, they sealed

• 

  Firm suspends production for 3 months after vaccine scandal

  The vaccine manufacturer that enraged the public for producing invalid rabies vaccines said on Wednesday that it has halted production and cannot operate in the next three months after 15 of its employees were detained.

• 

  Chinese internet companies launch online vaccine-tracking services following scandal

  Internet firms launch web vaccine-tracking servicesChinese internet giants in recent days have launched new online vaccine-tracking services, allowing concerned parents to check the safety of their children's vaccines.Concerned parents had previously been able to confirm the safety of these vaccines by checking with their local hospitals, but internet-savvy parents had been seeking information online. Search engine Sogou published data showing

• 

  CFDA to conduct thorough investigation of Changchun Changsheng

  The China Food and Drug Administration (CFDA) said Tuesday it will carry out a thorough inspection of all vaccine products and the entire production chain of Changchun Changsheng Life Sciences Limited.CFDA released a statement on its website vowing to follow up on the important instructions from Xi Jinping, general secretary of the Communist Party of China Central Committee, to work

• 

  Exemplary punishment must for makers of faulty drugs

  Although Changsheng immediately recalled the entire vaccine stock and said that no one contracted rabies or was harmed after receiving the vaccine, the scandal has triggered widespread concern about drug safety in China, and is sending ripples across society.Illustration: Liu Rui/Global TimesFraud is the No.1 enemy of customers. The jousting between authorities and counterfeiters will never end, and the government

• 

  15 suspects at Changchun Changsheng Life Sciences detained

  Fifteen people involved in an illegal vaccine production case involving Changchun Changsheng Life Sciences Limited have been detained, according to local authorities on Tuesday.Changchun Changsheng Life Sciences factory area (Photo: VCG)The group, including Chairwoman Gao Moufang, was detained by the Changchun New District Public Security Bureau. An investigation is underway, the police statement

• 

  Authorities investigate vaccine maker as scandal enrages public

  Parents consider imported vaccinesChina launched a nationwide inspection over the safety of vaccines amid a huge public outcry after evidence showed one of the country's largest vaccine makers fabricated data and provided substandard vaccines to children.Photos: VCGChangsheng Biotechnology Corporation, the country's second-largest maker of rabies vaccines and a major producer of vaccines for children, apologized in a statement late Sunday,

• 

  Public security began probe into Changchun Changsheng case

  Changchun’s Public Security Bureau began an investigation into the rabies vaccine case of Changchun Changsheng Life Sciences on Monday.Suspects in the criminal case involving the production and transport of freeze-dried human rabies vaccines, including the company’s chairwoman, Gao Mofang, and four other company executives were brought to the public security bureau for

• 

  Xi orders thorough investigation into vaccine case

  Chinese President Xi Jinping gave important instructions on the Changchun Changsheng Life Sciences case.He stressed the need for accountability. He said the country always puts the healthcare of the people first and upholds the safety as the bottom

• 

  Vaccine maker's stock tumbles amid safety scandal

  Changsheng share on July 23, 2018. (Photo: Sina finance)Vaccine stocks tumbled following the rabies vaccine scandal, as shares of the company at the center of the scandal temporarily suspended trading in the A-share market Monday morning.The China Food and Drug Administration (CFDA) earlier found Changchun fabricating production data and violating the country’s drug production quality management protocols.Shares of Changsheng resumed

• 

  Authoritative voice needed amid vaccine fear

  (Photo: Shanghai Daily)News about the vaccine scandal involving Changchun Changsheng is flooding the internet with public anger and panic. Vaccines directly concern the health of children and are related to life. Every item of negative news in this area attracts the attention of all society. Supervising and regulating the safe production of vaccines can be argued as a test of

• 

  Premier Li demands full investigation of vaccine case

  A child is vaccinated in a hospital in north China's Hebei Province. (Photo/Xinhua)Premier Li Keqiang said in an instruction that the vaccine case has crossed a moral line, and the nation deserves a clear explanation, the State Council said on its website on Sunday.The State Council should immediately send a group to investigate to uncover the truth as soon as

• 

  CFDA launches probe against vaccine maker amid scandal

  A Changchun-based anti-rabies vaccines producer apologized on Sunday following revelations of protocol breaches in its drug production.Changchun Changsheng Life Sciences, China’s second-largest rabies vaccine manufacturer, said in a written response to the Shenzhen Stock Exchange that it has halted the production of the Vero-cell anti-rabies vaccines and would take measures to clean it up.The China Food and Drug Administration (CFDA)

• 

  China's second-largest rabies vaccine maker to stop output after drug safety scandal

  File PhotoChina Food and Drug Administration (CFDA) has issued an announcement asking Changchun Changsheng Life Sciences, China’s second-biggest rabies vaccine maker, to terminate the production of its Vero-cell rabies vaccines.The announcement came after authorities carried out a snap inspection and found the company forging production data and violating the country’s drug production quality management protocols.CFDA's investigation annoucement against Changchun Changsheng's

• 

  State drug regulator continues vaccine scandal probe

  File photoThe disease control bureau of the National Health Commission of China is closely following developments in the anti-rabies vaccine production scandal, and is coordinating with the State Drug Administration (SDA), said bureau director Mao Qun'an.This is the latest comment from China's regulators after the drug safety scandal was exposed. Anti-rabies vaccines produced by Changchun Changsheng Biotech were found to